Oligomer Oy Company Profile

08:43 EDT 17th March 2018 | BioPortfolio



Latokartanonkaari 11 D-talo


Phone: 358- 9- 3478 900
Fax: 358-9- 3478 9090

News Articles [10 Associated News Articles listed on BioPortfolio]

Global Epoxidized Soybean Oil Acrylate Oligomer Market Research Report Forecast 20172022 [Report Updated: 18092017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Epoxidized Soybean Oil Acrylate Oligomer Market Research Report Forecast 20172022 is a valuable source of insightful data fo...

Alzheon To Make Presentations On ALZ-801 And Its Anti-Oligomer Mechanism At


Arcturus, Janssen team up once again

Arcturus Therapeutics Inc. will use its UNA oligomer chemistry and LUNAR platforms to create hepatitis B therapies for Janssen Pharmaceuticals Inc.

Alzheon to Make Presentations on ALZ-801 and Its Anti-Oligomer Mechanism at the 10th Clinical ...

Clinical Data and Research Support Advancement of ALZ-801 to Phase 3 Study as Oral Precision Medicine to Treat Alzheimer’s Disease Read more...

Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model

Oligomeric forms of amyloid-β (Aβ) and tau are increasing being recognized as key toxins in the pathogenesis of Alzheimer’s disease (AD).

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

Soluble amyloid-β (Aβ) oligomers are the major toxic substances associated with the pathology of Alzheimer’s disease (AD). The ability to measure Aβ oligomer levels in the blood would provide sim...

Arcturus Therapeutics Announces Expansion of Collaboration with...

Arcturus Therapeutics Ltd. , a leading RNA medicines company, announced today that it is extending its partnership with Takeda Pharmaceutical Company Limited . Under the collaboration, Takeda and Arct...

Designer Multipass Transmembrane Proteins the Latest Cellwear

Transmembrane proteins from the House of Nature are abundant, but they’re all off the rack. Yes, they have been tailored to serve diverse functions, from transmembrane transport to cell signaling, b...

Drugs and Medications [0 Results]


PubMed Articles [64 Associated PubMed Articles listed on BioPortfolio]

DFT Modeling of Crosslinked Polyethylene: Role of Gold Atoms and Dispersion Interactions.

Using DFT modeling we analyze the concerted action of gold atoms and dispersion interactions in crosslinked polyethylene. Our model consists of two oligomer chains (PEn) with 7, 11, 15, 19 or 23 carbo...

Oligomeric Nucleants: Simulations of Chain Length, Binding Strength, and Volume Fraction Effects.

Recent theories and simulations suggest that molecular additives can bind to the surfaces of nuclei, lower the surface energy, and accelerate nucleation. Experiments have shown that oligomeric and pol...

Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.

Alzheimer's disease is a progressive neurodegenerative disease characterized by the accumulation of amyloid-β (Aβ) in the brain. Aβ oligomers are believed to cause synapse damage resulting in the m...

Hydrothermal Growth of Centimeter-Scale CuO Plates: Planar Chromium(III) Oligomer as a Facet-Directing Agent.

In this work, a simple hydrothermal method was developed to synthesize CuO plates in centimeter scale for the first time. Plates of up to 20 μm thickness and several square millimeters in area have b...

Estrogens synthesized and acting within a spinal oligomer suppress spinal endomorphin 2 antinociception: ebb and flow over the rat reproductive cycle.

The magnitude of antinociception elicited by intrathecal endomorphin 2 (EM2), an endogenous mu-opioid receptor (MOR) ligand, varies across the rat estrous cycle. We now report that phasic changes in a...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid

AVI-4020 Injection, a phosphorodiamidate Morpholino oligomer (PMO), was found to cross the blood-brain barrier during a study of patients with presumptive West Nile virus disease. AVI-4065...

Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD), a fatal muscle degenerative disorder, arises from mutations in the dystrophin gene. Antisense therapy with the use of antisense oligonucleotides (AON) ha...

Companies [5 Associated Companies listed on BioPortfolio]

Oligomer Oy


Bio-Synthesis, Inc.

Bio-Synthesis Inc was the first commercial company providing DNA and peptides in 1984. We specialize in custom peptide synthesis from small to large scale and we can help you design the optimal pepti...


PolyMedix is the leader in developing biomimetics - novel small molecule, oligomer and polymer protein-mimetic drugs for membrane protein and protein:protein targets. PolyMedix has a proven computatio...

BioChrom Labs, Inc

Established in 1990, BioChrom Labs, Inc., Indiana, USA, is dedicated to developing and manufacturing polymeric materials using patentable and proprietary technologies. HYDROCELL HPLC Columns and packi...

Sarepta Therapeutics

Innovative RNA-Based Technology; First-in-Class Therapeutics Sarepta Therapeutics – formerly AVI BioPharma – remains focused on developing first-in-class, RNA-based therapeutics to imp...

More Information about "Oligomer Oy" on BioPortfolio

We have published hundreds of Oligomer Oy news stories on BioPortfolio along with dozens of Oligomer Oy Clinical Trials and PubMed Articles about Oligomer Oy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oligomer Oy Companies in our database. You can also find out about relevant Oligomer Oy Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record